Threading the Needle: Multi-omics Diagnosis and Discovery to Precision Breast Cancer Care
Medical oncologists, hematologists, gastroenterologists, pulmonologists, internists, surgeons, geneticists, palliative care specialists, basic and translational research scientists, residents, fellows, and medical students need to receive regular updates on advances in the diagnosis and management of hematologic disorders and malignancies. The series aims to expand the knowledge base of learners in these topic areas, improve their clinical competencies and research skills, enhance patient care, and improve outcomes.
Physicians, medical students, fellows, residents, and other health professionals.
At the conclusion of the session, the participants should be able to:
- Discuss robust and innovative biomarker-driven clinical trials integrating novel assays such as liquid biopsy, multi-omic analysis.
- Review the principle and importance of team science approach in modern translation research.
- Describe examples of bench to bedside to back to the bench.
- Summarize the future direction of the translational research.
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Thank you for reviewing this Baylor College of Medicine on-demand activity. In order to complete the evaluation and claim credit for your participation, please select the appropriate payment option above. After payment has been completed, you will receive an email confirmation and receipt.
For any questions, contact email@example.com.